News

Recent member news from the Sept. 15, 2022, Weekly Report... Read More >>

The Washington Health Care Authority has provided a form and billing instructions for hospitals and behavioral health facilities to be reimbursed for opioid reversal medication provided to uninsured patients as a result of Substitute Senate... Read More >>

Comments on the Centers for Medicare and Medicaid Services (CMS) proposed outpatient rule are due September 13. WSHA will submit comments by the deadline and has provided a draft of its comments to member... Read More >>

The Washington State Office of the Insurance Commissioner (OIC) has issued a second prepublication draft of rulemaking to implement E2SHB 1688. The proposal aligns portions of the state’s Balance Billing Protection Act... Read More >>

WSHA’s Government Affairs team recently published an update to its Top Priority Rules Tracker, which shows the highest-priority ongoing state rulemaking activities impacting hospitals and health systems as part of its State... Read More >>

The Association of Women’s Health and Neonatal Nurses (AWHONN), Washington Chapter, will host its fall conference Oct. 9-11 at Campbell’s Resort in Chelan. WSHA contributed to holding the event and WSHA Clinical Director Mary Kay Ausenhus will present on WSHA’s Perinatal Substance Use Disorder Learning Collaborative... Read More >>

September is National Recovery Month, which aims to educate the community about recovery from substance use disorder and celebrate friends, family, and community members living in recovery. National Recovery Month also comes immediately after International Overdose Awareness Day on August 31... Read More >>

This fall, the Association of Washington Public Hospital Districts (AWPHD) and WSHA will offer the three-part webinar series “Substance Use Disorder Care in Rural Settings: Reducing Barriers to Care.”... Read More >>

On Aug. 31, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination... Read More >>

Now that the new COVID-19 bivalent booster dose has progressed through the formal approval process, there is one final piece needed before Washington State health care providers can administer the vaccine... Read More >>